October 7th 2021
By Colleen Moretti
Dr. Curtis Mack can relate to his patients on a level other radiation oncologists might not be able to because he has received a diagnosis, gone through treatment and survived cancer himself.
By Andy Polhamus
Remission should lift the burden of cancer, but the effects that follow treatment may keep many cancer survivors from being able to sleep at night.
October 4th 2021
By Jamie Cesanek
Whether it be physical, psychosocial or financial, the lasting effects of cancer and its treatment can be overwhelming. One expert explains how a personalized survivorship care plan can tackle it altogether.
September 25th 2021
By Julie S. Brokaw
A woman writes a poem to thank the doctors and nurses who treated her ovarian cancer and changed her life.
September 22nd 2021
By Marissa Holzer
The process of scheduling and receiving scans to monitor your disease can be emotionally triggering and traumatic as a patient with cancer, one woman explains.
September 17th 2021
By Robin Zimmerman
A melanoma survivor and former caregiver analyzes the way society’s labels shape our behaviors and identities.
September 16th 2021
By William Ramshaw
A cancer survivor explains that similar to combat veterans who experience post-traumatic stress after war, cancer survivors live with the impacts of their journey even after being in remission.
Cancer survivors who identify as lesbian, gay or bisexual report experiencing significantly more challenges in their survivorship than their heterosexual peers, according to recent study results.
September 14th 2021
Residing in neighborhoods that are within walking distance of destinations such as shops, restaurants and bus stops was associated with a decrease in BMI among black cancer survivors.
September 13th 2021
By Kim Johnson
After enduring cancer, how does one celebrate completing treatments? A woman writes about celebrating all of her sister's successes, no matter how big or small.
Top Lung Cancer Stories from October: Insights, and Patient Journeys
How AI Can Put Patients at the Center of Cancer Care
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
Sharing More Than 25 Years of Brain Tumor Survival